EMA: Concept paper on the development of toxicological guidance for use in risk identification in the manufacture of different medicinal products in shared facilities

The Safety Working Party recommends drafting new guidance on toxicological assessment to be used in the risk identification stage of the Quality Risk Management process in determining whether a medicinal product should be manufactured in dedicated facilities.